1-4 of 4
Seok Jin Kim
Close
Sort by
Journal Articles

Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma

Clinical Trials & Observations
Loretta J. Nastoupil, Georg Hess, Miguel A. Pavlovsky, Iwona Danielewicz, Jane Freeman, Alejandro Martin García-Sancho, Valeria Glazunova, Andrew Grigg, Jing-Zhou Hou, Ann Janssens, Seok Jin Kim, Zvenyslava Masliak, Pam McKay, Francesco Merli, Wataru Munakata, Hirokazu Nagai, Muhit Özcan, Meir Preis, Tingyu Wang, Melissa Rowe, Monelle Tamegnon, Rui Qin, Todd Henninger, Madeliene Curtis, Donne Bennett Caces, Catherine Thieblemont, Gilles Salles
Journal: Blood Advances
Blood Adv (2023) 7 (22): 7141–7150.
https://doi.org/10.1182/bloodadvances.2023010298
Published: 2023
Includes: Supplemental data
Journal Articles

CD47 overexpression is common in intestinal non-GCB type diffuse large B-cell lymphoma and associated with 18q21 gain

Junhun Cho, Sang Eun Yoon, Seok Jin Kim, Young Hyeh Ko, Won Seog Kim
Journal: Blood Advances
Blood Adv (2022) 6 (24): 6120–6130.
https://doi.org/10.1182/bloodadvances.2021006305
Published: 2022
Journal Articles

A risk model for relapsed/refractory aggressive NHL integrating clinical risk factors and pretransplant Deauville score

Clinical Trials & Observations
Ho-Young Yhim, Yael Eshet, Ur Metser, Chae-Hong Lim, Katherine Lajkosz, Keren Isaev, Matthew Cooper, Anca Prica, Vishal Kukreti, Sita Bhella, Noémie Lang, Kyung-Han Lee, Wei Xu, David Hodgson, Richard Tsang, Sang Eun Yoon, Seok Jin Kim, Won Seog Kim, Michael Crump, John Kuruvilla, Robert Kridel
Journal: Blood Advances
Blood Adv (2020) 4 (22): 5762–5771.
https://doi.org/10.1182/bloodadvances.2020002814
Published: 2020
Includes: Supplemental data
Journal Articles

Progression of AITL-like tumors in mice is driven by Tfh signature proteins and T-B cross talk

Mariko Witalis, Jinsam Chang, Ming-Chao Zhong, Yasser Bouklouch, Vincent Panneton, Joanna Li, Thorsten Buch, Seok Jin Kim, Won Seog Kim, Young Hyeh Ko, André Veillette, Woong-Kyung Suh
Journal: Blood Advances
Blood Adv (2020) 4 (5): 868–879.
https://doi.org/10.1182/bloodadvances.2019001114
Published: 2020
Includes: Supplemental data